receptor
hemagglutin
encephalomyel
viru
hev
porcin
coronaviru
chicken
erythrocyt
analyz
compar
receptor
bovin
coronaviru
bcv
influenza
c
viru
evid
obtain
hev
requir
presenc
acid
cell
surfac
agglutin
erythrocyt
previous
shown
bcv
influenza
c
viru
incub
red
blood
cell
sialat
receptordestroy
enzym
influenza
c
viru
render
erythrocyt
resist
agglutin
three
virus
ii
human
erythrocyt
resist
agglutin
hev
acquir
receptor
hev
resialyl
sialyl
red
blood
cell
limit
amount
sialic
acid
indic
strain
influenza
c
viru
requir
less
agglutin
erythrocyt
two
coronavirus
found
similar
reactiv
contain
receptor
great
variat
among
member
famili
coronavirida
abil
agglutin
red
blood
cell
strain
jhm
mous
hepat
viru
complet
devoid
hemagglutin
activ
coronavirus
report
poor
hemagglutinin
instanc
transmiss
gastroenter
viru
noda
et
al
infecti
bronchiti
viru
bingham
et
al
sever
member
viru
famili
howev
quit
potent
hemagglutin
agent
includ
bovin
coronaviru
bcv
human
coronaviru
hemagglutin
encephalomyel
viru
hev
murin
coronavirus
kay
dowdl
pensaert
callebaut
sato
et
al
sugiyama
amano
inform
natur
erythrocyt
receptor
recogn
virus
becam
avail
recent
bcv
report
contain
sialat
vlasak
et
al
enzym
releas
residu
sialic
acid
previous
shown
present
influenza
c
virion
inactiv
cellular
receptor
influenza
c
viru
herrler
et
al
herrler
klenk
find
indic
acid
receptor
determin
attach
influenza
c
viru
cell
confirm
resialyl
studi
roger
et
al
esteras
bcv
influenza
c
viru
shown
inactiv
receptor
erythrocyt
bcv
well
vlasak
et
al
result
indic
receptor
determin
attach
bcv
erythrocyt
report
hemagglutin
activ
hev
also
depend
presenc
neusqac
erythrocyt
surfac
evid
present
strain
influenza
c
viru
effici
recogn
contain
receptor
hev
bcv
requir
similar
amount
sialic
acid
cell
surfac
order
caus
hemagglutin
strain
hev
obtain
dr
rg
hess
koblenz
frg
strain
bcv
provid
dr
r
rott
giessen
frg
coronavirus
grown
mdck
cell
sublin
madindarbi
canin
kidney
cell
maintain
describ
previous
herrler
et
al
adsorpt
period
min
c
inoculum
remov
infect
cell
incub
c
serumfre
eagl
minim
essenti
medium
mem
presenc
trypsin
pgml
viru
harvest
h
pi
supernat
usual
hatit
haunitsml
clarifi
low
speed
centrifug
follow
addit
fetal
calf
serum
lo
store
c
strain
influenza
c
viru
fowl
plagu
viru
influenza
grown
embryon
egg
describ
previous
herrler
klenk
klenk
et
al
hemagglutin
assay
perform
describ
previous
herrler
et
al
hemagglutin
titer
auml
indic
reciproc
valu
maximum
dilut
caus
complet
agglutin
hemagglutinationinhibit
assay
perform
describ
previous
herrler
et
al
purif
acetylesteras
influenza
c
viru
describ
previous
herrler
et
al
schauer
et
al
enzym
activ
defin
amount
acetylesteras
requir
releas
pmol
acet
bovin
submaxillari
gland
mucin
bsm
mm
c
sampl
contain
suspens
chicken
erythrocyt
pb
incub
c
presenc
differ
amount
purifi
acetylesteras
influenza
c
viru
min
red
blood
cell
wash
twice
pb
resuspend
ml
buffer
erythrocyt
use
determin
hatit
bcv
hev
influenza
c
viru
diphenylmethylest
acid
acetyl
use
acet
anhydridepyridin
u
rose
r
brossmer
prepar
hydrogen
palladiumoxid
afford
acid
detail
descript
publish
elsewher
prepar
enzymat
prepar
scale
use
partial
purifi
cmpsialic
acid
synthas
bovin
brain
gross
et
al
reaction
mixtur
compos
essenti
describ
previous
gross
et
al
except
ph
shift
group
labil
phvalu
prepar
assay
contain
mncl
instead
mm
mgcl
mm
ctp
accord
analyt
cmpsialic
acid
synthas
assay
develop
ph
gross
et
al
purif
achiev
semiprepar
hplc
gel
filtrat
gross
et
al
final
cmpglycosid
prepar
character
analyt
hplc
system
outlin
earlier
gross
et
al
acid
hydrolysi
molar
ratio
cmp
neusqac
contamin
free
cmp
ctp
even
prepar
free
impur
judg
tlc
gross
et
al
rat
liver
store
concentr
mupl
presenc
triton
deterg
remov
prior
sialyl
cell
accord
publish
method
holloway
carrol
et
al
enzym
mix
biobead
mg
wet
bead
per
enzym
pb
contain
bovin
serum
albumin
pb
per
mg
wet
bead
incub
min
c
supernat
remov
volum
fresh
pbsbsa
ad
bead
min
c
supernat
combin
use
sialyl
cell
cell
sialyl
essenti
describ
paulson
roger
use
rat
liver
suspens
human
erythrocyt
prepar
buffer
contain
nacl
mm
cacl
mm
me
ph
sampl
contain
ml
red
blood
cell
suspens
incub
mu
neuraminidas
vibrio
cholera
min
c
cell
wash
twice
pb
resuspend
pb
bsa
follow
addit
galplpglcnac
amount
cmpsialic
acid
indic
erythrocyt
incub
c
h
cell
wash
twice
resuspend
ml
pb
use
determin
hatit
bcv
hev
influenza
c
viru
rat
liver
galpl
rlglcnac
bovin
submaxillari
gland
mucin
purchas
boehring
mannheim
frg
vibrio
cholera
neuraminidas
behringwerk
marburg
frg
biobead
biorad
miinchen
frg
bovin
serum
albumin
cmpneusac
sigma
deisenhofen
frg
order
character
hemagglutin
activ
hev
hemagglutin
assay
perform
erythrocyt
known
differ
content
purpos
chicken
red
blood
cell
chosen
acetyl
sialic
acid
shown
development
marker
surfac
cell
present
erythrocyt
adult
chicken
cell
onedayold
chicken
herrler
et
al
addit
avian
cell
human
erythrocyt
use
chemic
analysi
fail
detect
sialic
acid
shukla
schauer
though
red
blood
cell
individu
may
low
amount
indic
hemagglutin
test
influenza
c
viru
nishimura
et
al
shown
tabl
among
virus
test
influenza
viru
abl
agglutin
cell
three
sourc
hev
found
agglutin
behavior
bcv
influenza
c
viru
hatit
virus
could
determin
erythrocyt
adult
chicken
cell
onedayold
chicken
human
erythrocyt
resist
agglutin
consid
type
sialic
acid
present
red
blood
cell
see
result
tabl
compat
receptor
determin
attach
hev
erythrocyt
import
agglutin
red
blood
cell
hev
analyz
pretreat
chicken
erythrocyt
sialat
oacetylesteras
enzym
isol
purifi
influenza
c
virion
herrler
et
al
follow
isol
hefprotein
influenza
c
viru
lack
hemagglutin
activ
retain
esteras
activ
shown
tabl
incub
acetylesteras
render
red
blood
cell
adult
chicken
resist
agglutin
hev
bcv
influenza
c
viru
howev
receptor
hev
bcv
sensit
enzym
treatment
receptor
influenza
c
viru
incub
erythrocyt
presenc
mu
acetylesteras
caus
reduct
hemagglutin
titer
hev
bcv
wherea
titer
influenza
c
viru
unaffect
increas
amount
enzym
mu
result
partial
reduct
hatit
influenza
c
viru
complet
resist
agglutin
coronavirus
result
confirm
role
receptor
determin
attach
hev
cell
indic
howev
influenza
c
viru
differ
coronavirus
abil
recogn
contain
receptor
influenza
c
viru
direct
evid
import
essenti
part
receptor
red
blood
cell
obtain
resialyl
human
erythrocyt
roger
et
al
approach
appli
bcv
hev
human
red
blood
cell
incub
neuraminidas
vibrio
cholera
releas
nativ
sialic
acid
asialocel
resialyl
use
purifi
rat
liver
specif
attach
sialic
acid
galactos
activ
sialic
acid
shown
tabl
neither
influenza
c
viru
coronavirus
bcv
hev
abl
agglutin
cell
resialyl
contain
surfac
high
hemagglutin
titer
obtain
howev
follow
attach
sialic
acid
cell
surfac
glycoprotein
asialocel
result
provid
proof
attach
virus
erythrocyt
involv
type
receptor
resialyl
method
use
compar
effici
two
coronavirus
influenza
c
viru
recogn
contain
receptor
reaction
condit
chang
reduc
amount
sialic
acid
attach
cell
surfac
purpos
limit
concentr
use
incub
red
blood
cell
sialyltransferas
shown
tabl
optim
hemagglutin
titer
influenza
c
viru
alreadi
obtain
pmol
use
sialyl
red
blood
cell
hemagglutin
bcv
detect
cell
incub
presenc
nmol
activ
sialic
acid
optim
titer
requir
nmol
resialyl
reaction
result
indic
hev
bcv
requir
minim
concentr
sialic
acid
cell
surfac
agglutin
erythrocyt
strain
influenza
c
viru
hand
effici
recogn
contain
receptor
red
blood
cell
two
coronavirus
test
result
demonstr
agglutin
erythrocyt
hev
requir
presenc
contain
receptor
cell
surfac
shown
previous
bcv
influenza
c
viru
roger
et
al
vlasak
et
al
follow
incub
sialat
red
blood
cell
resist
hemagglutin
activ
virus
ii
viru
receptor
gener
resist
erythrocyt
attach
cell
surfac
glycoprotein
use
resialyl
method
abl
compar
virus
respect
effici
recogn
contain
receptor
strain
influenza
c
viru
requir
less
sialic
acid
surfac
erythrocyt
hemagglutin
two
coronavirus
find
confirm
result
two
hemagglutinationinhibitor
bovin
submaxillari
mucin
rat
serum
lower
inhibitori
titer
obtain
hev
bcv
influenza
c
viru
shown
bovin
mucin
present
olink
oligosaccharid
gottschalk
et
al
sialic
acid
rat
dmacroglobulin
major
inhibitori
compound
rat
serum
herrler
et
al
kitam
et
al
primarili
found
nlink
biantennari
oligosaccharid
herrler
et
al
c
consid
differ
carbohydr
structur
two
inhibitor
conclud
strain
influenza
viru
increas
affin
compar
hev
bcv
neighbor
sugar
major
import
interact
far
differ
strain
influenza
c
viru
compar
respect
affin
mutant
strain
howev
isol
effici
recogn
contain
receptor
wild
type
szepanski
et
al
mutant
broader
cell
tropism
compar
parent
viru
interest
find
whether
mutant
increas
affin
cellular
receptor
obtain
coronavirus
mutat
affect
tropism
pathogen
viru
far
three
coronavirus
shown
use
contain
receptor
agglutin
erythrocyt
bcv
hev
coronavirus
contain
glycoprotein
implic
hemagglutin
ring
et
al
esteras
activ
viasak
et
al
correspond
protein
also
present
turkey
coronaviru
dea
et
al
murin
coronavirus
sugiyama
amano
also
potent
hemagglutin
agent
suppos
latter
virus
also
use
receptor
determin
attach
cell
coronavirus
lack
heprotein
virus
includ
infecti
bronchiti
viru
ibv
transmiss
gastroenter
viru
tgev
felin
infecti
periton
viru
attach
cell
mediat
sprotein
cavanagh
natur
receptor
recogn
virus
known
tgev
ibv
low
hemagglutin
activ
sensit
pretreat
erythrocyt
neuraminidas
bingham
et
al
noda
et
al
use
techniqu
resialyl
possibl
demonstr
whether
coronavirus
lack
heprotein
requir
sialic
acid
ceii
surfac
attach
cell
whether
recogn
receptor
heprotein
also
lack
strain
mous
hepat
viru
mhv
though
open
read
frame
protein
present
genom
viru
luytj
et
al
heprotein
correspond
mrna
detect
relat
strain
mhvjhm
mhv
shieh
et
al
pfleider
et
al
submit
data
report
use
kda
protein
receptor
boyl
et
al
futur
work
show
whether
protein
recogn
mous
hepat
viru
whether
serv
also
addit
contain
glycoconjug
receptor
hev
bcv
